There are currently three types of cervical cancer vaccines: bivalent, quadrivalent and nine-valent vaccines, and the prices of the three vaccines are different and vary from region to region. Cervical cancer is the most common gynecological malignancy. Due to the increased awareness of women’s medical checkups and gynecological cervical exfoliation cytology in recent years, the incidence of cervical cancer has been greatly reduced. The introduction of the cervical cancer vaccine has undoubtedly brought protection to women. However, the vaccine is not available in all areas and is currently available in China’s first-tier cities: Beijing, Shenzhen and Shanghai. The bivalent vaccine is suitable for women aged 9-25 and protects against infection by HPV 16 and HPV 18 viruses. The quadrivalent vaccine is suitable for women aged 20-45 years and protects against HPV infections by HPV types 6, 11, 16 and 18. The nine-valent vaccine is for women aged 16-26 years and targets nine subtypes of HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58. The nine-valent vaccine can prevent 90% of cervical cancers. Take the cervical cancer vaccine in Shenzhen as an example: the prices of the bivalent, quadrivalent and nine-valent vaccines are about 600, 800 and 1,200 yuan respectively. Each vaccine requires three doses on time. The time required for vaccination varies from one vaccine to another. Even after receiving the cervical cancer vaccine, screening for cervical cancer is still necessary. Regular cervical exfoliative cell HPV and TCT examinations are performed annually.